DIST_0330_pnas.2015433118

CXCR4 antagonist identified for hepatocellular carcinoma

Apr 7, 2021 | 5:05 PM GMT

DISEASE CATEGORY: Cancer

INDICATION: Liver cancer

An oxopropylaminoacetic acid-based CXCR4 antagonist could treat hepatocellular carcinoma (HCC). The CXCR4 inhibitor, optimized from

Read the full 297 word article

How to gain access

Continue reading with a
two-week free trial.